Papers in BJC Reports
Page 3 · newest first
- Deep learning-based interpretable prediction of recurrence of diffuse large B-cell lymphomaBJC Reports · 2025
- Assessing the risk of second primary lung cancer in women after previous breast cancerBJC Reports · 2025
- Increasing incidence of early-onset kidney cancer in young adults aged <50 years in England: an analysis of the national cancer registration data by age and gender, 1985–2020BJC Reports · 2025
- Association of HER2 amplification or overexpression with overall survival in advanced upper gastrointestinal adenocarcinomasBJC Reports · 2025
- Genomics and integrative clinical data machine learning scoring model to ascertain likely Lynch syndrome patientsBJC Reports · 2025
- Case report of three patients with end-stage recurrent glioblastoma treated with meldoniumBJC Reports · 2025
- Cancer risk according to lifestyle risk score trajectories: a population-based cohort studyBJC Reports · 2025
- Metabolic reprogramming in glioblastoma: a rare case of recurrence to scalp metastasisBJC Reports · 2025
- Exploring the effect of differing centre hydration and anti-emetic policies on acute gastrointestinal and renal toxicities in the De-ESCALaTE trialBJC Reports · 2025
- Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastasesBJC Reports · 2025
- An aspirin a day keeps cancer at bayBJC Reports · 2025
- Solid lipid nanoparticles in pancreatic cancer treatmentBJC Reports · 2025
- Increasing use of artificial intelligence in genomic medicine for cancer care- the promise and potential pitfallsBJC Reports · 2025
- Tumour measurements on imaging for clinical trial: A national picture of service provisionBJC Reports · 2025
- Germline copy number variants in RUNX1: An updated case report and a decade-old red herringBJC Reports · 2025
- A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancersBJC Reports · 2025
- A novel multigene panel (Sig27) robustly predicts poor prognosis of renal cell carcinoma via high-level associations with immunosuppressive featuresBJC Reports · 2025
- Epidemiology of multimorbidity in childhood cancer survivors: a matched cohort study of inpatient hospitalisations in Western AustraliaBJC Reports · 2025
- Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic reviewBJC Reports · 2025
- Deep-learning enabled combined measurement of tumour cell density and tumour infiltrating lymphocyte density as a prognostic biomarker in colorectal cancerBJC Reports · 2025
- Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping reviewBJC Reports · 2025
- Activation of FGFR genes by genetic and epigenetic alterations in uterine leiomyomasBJC Reports · 2025
- Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistanceBJC Reports · 2025
- CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumoursBJC Reports · 2025
- HER2 amplification and HER2 low expression in endometrial carcinoma: prevalence across molecular, histological and clinicopathological risk groupsBJC Reports · 2025
- The relationship between tumour necrosis, systemic inflammation, body composition and survival in patients with colon cancerBJC Reports · 2025
- A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltrationBJC Reports · 2025
- Towards greener and more sustainable pre-clinical oncology researchBJC Reports · 2025
- Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacyBJC Reports · 2025
- A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumorsBJC Reports · 2025
- Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinomaBJC Reports · 2025
- Long term follow-up of women treated for screen detected atypical ductal hyperplasia or lobular neoplasia in a large UK screening centreBJC Reports · 2024
- Increased potentiation of 5-fluorouracil induced thymidylate synthase inhibition by 5,10-methylenetetrahydrofolate (arfolitixorin) compared to leucovorin in patients with colorectal liver metastases; The Modelle-001 TrialSHILAP Revista de lepidopterología · 2024
- Single-cell RNA-seq analysis of cancer-endothelial cell interactions in primary tumor and peritoneal metastasis from a single patient with colorectal cancerBJC Reports · 2024
- Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancerBJC Reports · 2024
- Efficacy and safety of sacituzumab govitecan Trop-2-targeted antibody-drug conjugate in solid tumors and UGT1A1*28 polymorphism: a systematic review and meta-analysisBJC Reports · 2024
- Systematic review of risk prediction tools for primary cutaneous melanoma outcomes and validation of sentinel lymph node positivity prediction in a UK tertiary cohortBJC Reports · 2024
- Using the Candidacy Framework to understand individual, interpersonal, and system level factors driving inequities in women with breast cancer: a cross-sectional studyBJC Reports · 2024
- Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational studyBJC Reports · 2024
- Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancerBJC Reports · 2024
- Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancerBJC Reports · 2024
- Survival benefit of cytoreductive surgery in patients with primary stage IV endometrial cancer: a systematic review & meta-analysisSHILAP Revista de lepidopterología · 2024
- Head and neck cancer mortality in the United States: Regional differences in hospice use and place of deathBJC Reports · 2024
- Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumorsBJC Reports · 2024
- Breast cancer risk assessment based on susceptibility genes and polygenic risk score in Vietnamese womenBJC Reports · 2024
- Tumour reoxygenation after intratumoural hydrogen peroxide (KORTUC) injection: a novel approach to enhance radiosensitivityBJC Reports · 2024
- ASSIGN score and cancer risk in the Scottish Heart Health Extended Cohort (SHHEC) studyBJC Reports · 2024
- Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancerBJC Reports · 2024
- CNS prophylaxis is (mostly) futile in DLBCLBJC Reports · 2024
- Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgeryBJC Reports · 2024